课题基金 / 基金详情

Stem Cell and Transplantation Biology

Stem Cell and Transplantation Biology
干细胞和移植生物学
批准号:
10675711
负责人:
DEREK L STIREWALT
金额:
$63.28万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-08-01 至 2026-07-31
关键词:

项目摘要

项目成果

DEREK L STIREWALT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT - Overall The theme of this CCEH is focused on stem cell and transplantation biology. The aims are designed to overcome obstacles that prevent new investigators from joining this field. Specifically the four cores will provide investigators access to: Large numbers of human and canine stem/progenitor cells; Scalable viral production services for AAV, gamma-, lenti- and foamy viruses; Products for precision gene editing and functional genetic manipulation; PCR assays for tracking chimerism, and insertion sites; Xenografting to assess human hematopoiesis; Large animal model for preclinical in vivo testing and disease modeling. The major goal of this CCEH is to make these services available throughout the US. For this purpose, products and services must be cost- effective and of high quality. Also training in best practices for the use of these resources is imperative. Towards this goal core staff provide on-site training: funds to support travel to attend training sessions are available. In addition, standard operating procedures (SOP) and quality control measures (QC) for all processes and products are shared on our website where they can be discussed and amended as the science evolves. The logistics of distributing products throughout the country are challenging. However, since the first iteration of this grant (P30 DK056465) in 1999 we have successfully shipped highly purified CD34 cells in liquid nitrogen to hundreds of satisfied investigators. Our costs are generally less than 1/3 of the cheapest commercial vender, and our product is better. Logistics for shipping other biological products to out of state users are already in place. The fees for service charged by this CCEH generates program income of $1-2 million per year. These funds are used to increase staff, develop new technologies and to fund the Enrichment Program. The goal is to help build a strong, diverse, interactive hematology research community. Included in this effort is a research internship program for students from underrepresented or underserved populations. The Seattle CCEH research base consists of 25 faculty members at the University of Washington and/or the Fred Hutchinson Cancer Research Center. Currently our research base brings in $17,130,946 in direct costs per year for studies in non-malignant hematopoiesis.
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0197686
发表时间: 2018
期刊: PloS one
影响因子: 3.7
作者: [Hullar MAJ, Lampe JW, Torok-Storb BJ, Harkey MA]
通讯作者: Harkey MA
DOI: 10.1038/leu.2017.57
发表时间: 2017-10
期刊: Leukemia
影响因子: 11.4
作者: [Sommermeyer D, Hill T, Shamah SM, Salter AI, Chen Y, Mohler KM, Riddell SR]
通讯作者: Riddell SR
Correction: Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS.
修正:造血干细胞衍生的嵌合抗原受体 T 细胞在非人灵长类 HIV/AIDS 模型中的长期存在和功能。
DOI: 10.1371/journal.ppat.1006891
发表时间: 2018
期刊: PLoS pathogens
影响因子: 6.7
作者: [Zhen,Anjie, Peterson,ChristopherW, Carrillo,MayraA, Reddy,SowmyaSomashekar, Youn,CindyS, Lam,BriannaB, Chang,NelsonY, Martin,HeatherA, Rick,JonathanW, Kim,Jennifer, Neel,NickC, Rezek,ValerieK, Kamata,Masakazu, Chen,IrvinSY, Zack,]
通讯作者: Zack,
DOI: 10.1038/nbt.3461
发表时间: 2016-04
期刊: Nature biotechnology
影响因子: 46.9
作者: [Liu L, Sommermeyer D, Cabanov A, Kosasih P, Hill T, Riddell SR]
通讯作者: Riddell SR
20
    Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
    Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
    Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
    Stem Cell and Transplantation Biology
    • 批准号:
      10472478
    • 项目类别:
    • 资助金额:
      $63.28万
    • 财政年份:
      2015
    • 负责人:
      DEREK L STIREWALT
    • 依托单位:
    海外基金